DRIs is the general term for a set of reference values or guidelines that are used to plan and asses nutrient intakes of healthy people. These values which vary by age and gender include:
- Recommended Dietary allowance (RDA): average daily level of intake sufficient to meet nutrient requirements of about 97 - 98% of healthy people.
-Adequate intake (AI): established when evidence is not sufficient to develop an RDA and is set at a level assumed to ensure nutritional adequacy.
- Tolerable Upper Intake (UL): Maximum daily intake unlikely to cause adverse health effects.
DRIs are not necessarily found on labels because there is no law requiring that they must be placed there.
Answer:
the overlapping decreases between the thin and thick filaments.
Explanation:
When w extend our hand or arm to the full and try to lift any heavy object, we are unable to lift the object inspite of applying all our force. We struggle hard to lift the object with our fully extended arm because when we extend our arm fully it decreases the overlapping of our thin and the thick filaments of our muscles which makes it difficult to lift. In other words, the resting length of our arm is the optimal length to generate force.
<span>Science is always changing and never completely proves anything because </span>uncertainty <span>is part of the scientific process
</span>
Answer:
Pylorus
Explanation:
The stomach is a J-shaped organ which is a part of the digestive system. The digestive system on one end is attached to the oesophagus and on the end to the small intestine.
The pylorus structure of the stomach is composed of thick muscles which help to mix or agitating the food in the stomach and controls the movement of the food to the duodenum which is the first part of the small intestine. The movement is controlled by the ring of muscles in the pylorus called pyloric sphincter.
Thus, Pylorus is the correct answer.
Xigris (Drotrecogin alfa) is not an antibiotic but is approved for the specific indication of sepsis because of its anticoagulant properties.
Xigris (Drotrecogin alfa) is a drug approved by the Food and Drug Administration for the reduction of mortality in adult patients with severe sepsis who have a high risk of death. Xigris (Drotrecogin alfa) is placed under the class of serine proteases and it has anticoagulant, anti-thrombotic, anti-inflammatory, and profibrinolytic properties.
